International Stem Cell (ISCO) Short Interest Ratio & Short Volume

Short interest is the volume of International Stem Cell shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 100 shares of ISCO short. Learn More on International Stem Cell's current short interest.

International Stem Cell saw a increase in short interest in December. As of December 15th, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to International Stem Cell: Abliva AB (publ) (0.00%), Anthera Pharmaceuticals, Inc. (0.06%), Aravive, Inc. (1.81%), Context Therapeutics Inc. (0.08%), Grifols, S.A. (2.32%), IMV Inc. (1.31%), LAVA Therapeutics (1.50%), and Mainz Biomed (2.34%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($4.67 billion), General Motors ($4.33 billion), T-Mobile US, Inc. ($4.30 billion), Charter Communications, Inc. ($3.12 billion), Coinbase Global, Inc. ($3.12 billion), Occidental Petroleum Co. ($2.94 billion), Tractor Supply ($2.71 billion), Rivian Automotive, Inc. ($2.32 billion), United Rentals, Inc. ($2.22 billion), and Royal Caribbean Cruises Ltd. ($2.04 billion). View all of the most shorted stocks.

Short selling ISCO is an investing strategy that aims to generate trading profit from International Stem Cell as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for International Stem Cell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ISCO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ISCO, twice per month. The most recent reporting period available is December, 15 2023.